Intimation Under Regulation 30 of the SEBI (Listing obligation and Disclosure Requirements) Regulations, 2015- Submission of Press Release/ Media Release.

असफ(cid:334) हॉ(cid:729)ीटल सबके िलए (cid:738)ा(cid:726) AHL/AO/2026/1341 Date: 07 August 2026 The Listing Department BSE Limited 25th Floor, Phiroze Jeejeebhoy Towers Dalal Street Mumbai – 400 001 Sub: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Submission of Press Release / Media Release Ref: Scrip Code: 543943 Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Press Release titled "Extract of Unaudited Standalone and Consolidated Financial Results for the Quarter Ended 30 June 2026", issued by the Company today. The same is being submitted for your information and dissemination. Kindly take the above information on record and acknowledge the receipt of the same. Thanking you. Yours faithfully, For Asarfi Hospital Limited UDAI PRATAP SINGH Managing Director DIN: 08453794 Asarfi Hospital Limited Baramuri, P.O.: B Polytechnic, Dhanbad 828 130 || CIN: L85110JH2005PLC011673 Branch Office: Khatal Road, Dhaiya, ISM, Dhanbad 826004 || www.asarfihospital.com Phone: 7808368888, 9234302735 || Email: info@asarfihospital.com Asarfi Hospital Ltd CIN: L85110JH2005PLC011673 Regd. Office: 4th Floor, Asarfi Hospital, Baramuri, Bishunpur, Polytechnic, Dhanbad, Jharkhand –828130, India Phone: 9608833708 | E-Mail: cs@asarfihospital.com | Website: www.asarfi.in Leading Dhanbad-based healthcare provider with a 20-year operating track record, running two hospitals across super-specialtyandoncologycare,deliveringintegratedhealthcareservicesunderoneroof,spanningcriticalcare, emergencycare,cardiaccare,oncology,diagnostics,andothermulti-specialtyservices. Revenue (Rs in Lakhs) EBITDA (Rs in Lakhs) EBIT (Rs in Lakhs) 4,734 942 688 3,566 703 549 Q1’FY26 Q1’FY27 Q1’FY26 Q1’FY27 Q1’FY26 Q1’FY27 PAT (Rs in Lakhs) ROCE (%) Debt to Equity (x) 427 17% 0.60 320 14% 0.59 Q1’FY26 Q1’FY27 FY25 FY26 FY25 FY26  Stronggrowthwithmarginexpansion:Q1’FY27revenuerose33%YoYto₹4,734Lakhs,withEBITDAmarginat20%andPAT marginat9%,drivenbybetterrealizations,improvedARPOBandenhancedcasemixacrossbothhospitalunits.  Operationalmomentumacrossunits:Q1’FY27IPDrevenuegrew31%YoYandOPDrevenueincreased44%YoY,supported bygrowthinpatientvolumesandhigherrealizations;ARPOBincreasedto₹23,498(Super-Specialty)and₹31,892(Cancer Unit).  Specialty-ledperformance:Growthwasdrivenbyhigh-acuityspecialtiesincludingCardiology,Neurosciences,Orthopaedics andObstetrics&GynaecologyintheSuper-Specialtyunit,alongwithimprovedtractioninRadiationOncologyandMedical OncologyattheCancerunit,strengtheningoverallrevenuemixandcomplexityofcare. EXTRACT OF UNAUDITED STANDALONE AND CONSOLIDATED FINANCIAL RESULTS FOR THE QUARTER ENDED JUNE 30, 2026 (₹ in Lakhs) STANDALONE CONSOLIDATED Quarter Ended Quarter Ended Sl. No Particulars 30.06.2026 30.06.2025 30.06.2026 30.06.2025 (Unaudited) (Unaudited) (Unaudited) (Unaudited) 1 Revenue from operations 4,734.47 3,566.41 4,753.41 3,568.11 2 Other Income 59.26 141.63 56.59 141.63 3 Total Income 4,793.73 3,708.04 4,810.00 3,709.74 4 Profit before Taxes 570.74 427.14 570.62 419.61 5 Profit after Taxes 426.84 319.64 426.72 312.11 6 Paid-up Equity Share Capital 1,967.73 1,967.73 1,967.73 1,967.73 EPS (FV per share of Rs 10/-each) 7 -Basic (in Rs) 2.17 1.62 2.17 1.59 -Diluted (in Rs) 2.17 1.62 2.17 1.59 Notes: 1.TheUnauditedStandaloneandConsolidatedFinancialResultsfortheQuarterendedJune30,2026havebeenreviewedandrecommendedbythe AuditCommitteeandapprovedbytheBoardofDirectorsoftheCompanyattheirrespectivemeetingsheldonAugust07,2026. 2.TheaboveisanextractofthedetailedformatofUnauditedStandaloneandConsolidatedFinancialResultsfortheQuarterendedJune30,2026filed withStockExchangesunderRegulation33oftheSecuritiesandExchangeBoardofIndia(ListingObligationsandDisclosureRequirements)Regulations, 2015.ThefullformatoftheaboveFinancialResultsareavailableonthewebsitesofBombayStockExchange(www.bseindia.com)andCompany's websiteatwww.asarfi.in. For and on behalf of Board of Director Asarfi Hospital Limited Sd/- UdaiPratapSingh Place: Dhanbad Managing Director Date: August 07, 2026 DIN: 08453794